379 related articles for article (PubMed ID: 7530584)
1. Long-term exposure to high levels of corticosterone aggravates AF64A-induced cholinergic hypofunction in rat hippocampus in vivo.
Amoroso D; Kindel G; Wülfert E; Hanin I
Brain Res; 1994 Oct; 661(1-2):9-18. PubMed ID: 7530584
[TBL] [Abstract][Full Text] [Related]
2. Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A).
Hörtnagl H; Berger ML; Havelec L; Hornykiewicz O
J Neurosci; 1993 Jul; 13(7):2939-45. PubMed ID: 7687281
[TBL] [Abstract][Full Text] [Related]
3. Reversible cholinergic changes induced by AF64A in rat hippocampus and possible septal compensatory effect.
el Tamer A; Corey J; Wülfert E; Hanin I
Neuropharmacology; 1992 Apr; 31(4):397-402. PubMed ID: 1522957
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside AGF2 promotes task-specific recovery and attenuates the cholinergic hypofunction induced by AF64A.
Emerich DF; Walsh TJ
Brain Res; 1990 Sep; 527(2):299-307. PubMed ID: 2253037
[TBL] [Abstract][Full Text] [Related]
5. Effects of AF64A on gene expression of choline acetyltransferase (ChAT) in the septo-hippocampal pathway and striatum in vivo.
Fan QI; Hanin I
Neurochem Res; 1999 Jan; 24(1):15-24. PubMed ID: 9973232
[TBL] [Abstract][Full Text] [Related]
6. Deficits in cholinergic neurotransmission markers induced by ethylcholine mustard aziridinium (AF64A) in the rat hippocampus: sensitivity to treatment with the monoamine oxidase-B inhibitor L-deprenyl.
Ricci A; Mancini M; Strocchi P; Bongrani S; Bronzetti E
Drugs Exp Clin Res; 1992; 18(5):163-71. PubMed ID: 1490432
[TBL] [Abstract][Full Text] [Related]
7. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions.
Mouton PR; Meyer EM; Dunn AJ; Millard W; Arendash GW
Brain Res; 1988 Mar; 444(1):104-18. PubMed ID: 3359282
[TBL] [Abstract][Full Text] [Related]
8. Clonidine prevents transient loss of noradrenaline in response to cholinergic hypofunction induced by ethylcholine aziridinium (AF64A).
Hörtnagl H; Potter PE; Singer EA; Kindel G; Hanin I
J Neurochem; 1989 Mar; 52(3):853-8. PubMed ID: 2918312
[TBL] [Abstract][Full Text] [Related]
9. Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo.
Leventer SM; Wulfert E; Hanin I
Neuropharmacology; 1987 Apr; 26(4):361-5. PubMed ID: 3587537
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent effect of AF64A on cholinergic activity in the septo-hippocampal pathway of the rat brain: decreased responsiveness in aged rats.
El Tamer A; Wülfert E; Hanin I
Neurosci Lett; 1996 Jan; 203(2):123-6. PubMed ID: 8834109
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor induced stimulation of septal choline acetyltransferase activity in ethylcholine mustard aziridinium treated rats.
Willson CA; Hanin I
Neurosci Lett; 1997 Jul; 229(3):149-52. PubMed ID: 9237480
[TBL] [Abstract][Full Text] [Related]
12. Cholinotoxic effects on acetylcholinesterase gene expression are associated with brain-region specific alterations in G,C-rich transcripts.
Lev-Lehman E; el-Tamer A; Yaron A; Grifman M; Ginzberg D; Hanin I; Soreq H
Brain Res; 1994 Oct; 661(1-2):75-82. PubMed ID: 7834388
[TBL] [Abstract][Full Text] [Related]
13. AF64A (ethylcholine mustard aziridinium) impairs acquisition and performance of a spatial, but not a cued water maze task: relation to cholinergic hypofunction.
Opello KD; Stackman RW; Ackerman S; Walsh TJ
Physiol Behav; 1993 Dec; 54(6):1227-33. PubMed ID: 7507594
[TBL] [Abstract][Full Text] [Related]
14. Changes of cholinergic, noradrenergic and serotonergic synaptic transmission indices elicited by ethylcholine aziridinium ion (AF64A) infused intraventricularly.
Eva C; Fabrazzo M; Costa E
J Pharmacol Exp Ther; 1987 Apr; 241(1):181-6. PubMed ID: 2437288
[TBL] [Abstract][Full Text] [Related]
15. Sector-dependent neurotoxicity of ethylcholine aziridinium (AF64A) in the rat hippocampus.
Laganiere S; Marinko M; Corey J; Wulfert E; Hanin I
Neuropharmacology; 1990 Oct; 29(10):961-4. PubMed ID: 2255388
[TBL] [Abstract][Full Text] [Related]
16. Septohippocampal adaptive GABAergic responses by AF64A treatment.
Ayala-Grosso CA; Urbina-Paez R
J Neurosci Res; 1999 Jan; 55(2):178-86. PubMed ID: 9972820
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of high affinity choline transport attenuates both cholinergic and non-cholinergic effects of ethylcholine aziridinium (AF64A).
Potter PE; Tedford CE; Kindel G; Hanin I
Brain Res; 1989 May; 487(2):238-44. PubMed ID: 2525061
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic deficit induced by ethylcholine aziridinium (AF64A) in rat hippocampus: effect on glutamatergic systems.
Hörtnagl H; Berger ML; Reither H; Hornykiewicz O
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):213-9. PubMed ID: 1682822
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight glycosaminoglycan C3 attenuates AF64A-stimulated, low-affinity nerve growth factor receptor-immunoreactive axonal varicosities in the rat septum.
Dudas B; Rose M; Cornelli U; Hanin I
Brain Res; 2005 Feb; 1033(1):34-40. PubMed ID: 15680337
[TBL] [Abstract][Full Text] [Related]
20. Selective presynaptic cholinergic neurotoxicity following intrahippocampal AF64A injection in rats.
Mantione CR; Zigmond MJ; Fisher A; Hanin I
J Neurochem; 1983 Jul; 41(1):251-5. PubMed ID: 6688090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
